In Silico Identification of an Aryl Hydrocarbon Receptor Antagonist with Biological Activity In Vitro and In Vivo

The aryl hydrocarbon receptor (AHR) is critically involved in several physiologic processes, including cancer progression and multiple immune system activities. We, and others, have hypothesized that AHR modulators represent an important new class of targeted therapeutics. Here, ligand shape–based v...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Parks, Ashley J., Pollastri, Michael P., Hahn, Mark E., Stanford, Elizabeth A., Novikov, Olga, Franks, Diana G., Haigh, Sarah E., Narasimhan, Supraja, Ashton, Trent D., Hopper, Timothy G., Kozakov, Dmytro, Beglov, Dimitri, Vajda, Sandor, Schlezinger, Jennifer J., Sherr, David H.
Formato: Artigo
Lenguaje:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2014
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201140/
https://ncbi.nlm.nih.gov/pubmed/25159092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.114.093369
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares